Notalgia Paresthetica (NP) Case Study
Click here for a PDF version of this case study
Study Characteristics
- Study Phase: II
- Patient Population: 126 patients with Notalgia Paresthetica (NP) (Pruritus associated with NP)
- IP Route of Administration: Systemic (oral)
- Site Distribution: 33 sites (USA and Canada)
- Study Procedures: Photographs, Pharmacokinetics, Electrocardiograms
Study Challenges
- Patient awareness: Challenge in advertisement as patients are often unaware of the name of their condition
- Run-in period (screening): To ensure the enrollment of highly compliant patients and those with consistent itch
- Patient compliance: Primary endpoints were relying on patient-reported assessments
- Uncommon indication: PI with little experience in this indication
Study Highlights
Increased support for low-performing sites
Engaged with low-enrolling sites to ensure proper use of their local campaign budget
Creative advertising
Digital and local innovative marketing tactics to encourage patients to participate
Notalgia paresthetica cro specialty
Innovaderm managed 100% of the notalgia paresthetica studies (as per clinical trials.gov)
High compliance rate
Additional patient compensation for fully completed diary
Newsletter
Join our science community with Press Forward, our quarterly newsletter. Get the latest in dermatology clinical research. Subscribe now!
Newsletter subscription resources
